Analyst Ratings for Halozyme Therapeutics (HALO)

HALO Rating Summary

HALO Price Target Summary

* Over Last 12-Mos
  |   Expand Research on HALO
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $13.70 (+47.5%) * Over Last 12-Mos
Rating Score: 8 / 10
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
7/11/2014 JPMorgan New Coverage Overweight
(N/A)
13.00
(N/A)
9.29 9.29 0% Details
6/12/2014 UBS Upgrade Buy
(Neutral)
N/A
(N/A)
9.39 9.29 -1.06% Details
Like HALO Ratings? Also take a look at BAX, RHHBY

HALO Ratings News